bioMérieux receives De Novo FDA Authorization for its BIOFIRE Joint Infection (JI) Panel
The BIOFIRE solution is a U.S. FDA-cleared and CE-marked closed multiplex PCR and fully automated system that integrates sample preparation, amplification, and detection